D E Brenneman|S K McCune|I Gozes - JoVE Visualize

Showing results (21-30 of 203) with videos related to

Pageof 21

Sort By:

Nature|March 11, 1993

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryosP Gressens, J M Hill, I Gozes, et al.

Journal of Molecular Neuroscience : MN|April 17, 2001

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stressR A Steingart, B Solomon, D E Brenneman, et al.

Advances in Neuroimmunology|January 1, 1994

gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systemsD E Brenneman, S K McCune, R F Mervis, et al.

Peptides|January 1, 1991

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratJ M Hill, I Gozes, J L Hill, et al.

Brain Research|April 28, 2000

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's diseaseD Offen, Y Sherki, E Melamed, et al.

Regulatory Peptides|October 27, 1999

Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanismsH Y Wang, X Jiang, I Gozes, et al.

Annals of the New York Academy of Sciences|February 3, 1999

VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptideD E Brenneman, G Glazner, J M Hill, et al.

Annals of the New York Academy of Sciences|February 17, 2000

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophismD E Brenneman, J Hauser, T M Phillips, et al.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|June 1, 1995

Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survivalD E Brenneman, J M Hill, G W Glazner, et al.

The Journal of Clinical Investigation|June 15, 1997

Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factorD A Dibbern, G W Glazner, I Gozes, et al.

Pageof 21

Showing results (21-30 of 203) with videos related to

Sort By:

Pageof 21

Nature|March 11, 1993

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryosP Gressens, J M Hill, I Gozes, et al.

Journal of Molecular Neuroscience : MN|April 17, 2001

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stressR A Steingart, B Solomon, D E Brenneman, et al.

Advances in Neuroimmunology|January 1, 1994

gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systemsD E Brenneman, S K McCune, R F Mervis, et al.

Peptides|January 1, 1991

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratJ M Hill, I Gozes, J L Hill, et al.

Brain Research|April 28, 2000

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's diseaseD Offen, Y Sherki, E Melamed, et al.

Regulatory Peptides|October 27, 1999

Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanismsH Y Wang, X Jiang, I Gozes, et al.

Annals of the New York Academy of Sciences|February 3, 1999

VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptideD E Brenneman, G Glazner, J M Hill, et al.

Annals of the New York Academy of Sciences|February 17, 2000

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophismD E Brenneman, J Hauser, T M Phillips, et al.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|June 1, 1995

Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survivalD E Brenneman, J M Hill, G W Glazner, et al.

The Journal of Clinical Investigation|June 15, 1997

Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factorD A Dibbern, G W Glazner, I Gozes, et al.

Pageof 21